Phlebitis in Intravenous Amiodarone Administration: Incidence and Contributing Factors
نویسندگان
چکیده
منابع مشابه
Peripheral intravenous catheter related phlebitis and its contributing factors among adult population at KU Teaching Hospital.
BACKGROUND Peripheral intravenous catheter-related phlebitis is a common and significant problem in clinical practice. This study was carried out to determine the occurrence of peripheral intravenous catheter related phlebitis and to define the possible factors associated to its development. MATERIALS AND METHODS Prospective observational study was carried out on 230 clients who were under fi...
متن کاملPostinfusion Phlebitis: Incidence and Risk Factors
Objective. To document the incidence of postinfusion phlebitis and to investigate associated risk factors. Design. Analysis of existing data set from a large randomized controlled trial, the primary purpose of which was to compare routine peripheral intravascular catheter changes with changing catheters only on clinical indication. Participants and Setting. Patients admitted to a large, acute g...
متن کاملIncidence and severity of phlebitis in patients receiving peripherally infused amiodarone.
BACKGROUND Nurses noted that the rate of phlebitis was high when intravenous amiodarone was infused via a peripheral site. Hospital policy recommends a central vascular catheter, but this method is often not feasible because the drug is administered in emergent situations for short periods. OBJECTIVE To determine the rate and severity of phlebitis in patients given peripherally infused amioda...
متن کاملPeripheral intravenous catheter-related phlebitis and related risk factors.
INTRODUCTION Peripheral intravenous catheter-related phlebitis is a common and significant problem in clinical practice. This study aims to investigate the incidence of phlebitis and to evaluate some important related factors. METHODS 300 patients admitted to medical and surgical wards of hospitals in Semnan, Iran from April 2003 to February 2004 were prospectively studied. Variables evaluate...
متن کاملIntravenous amiodarone.
Intravenous amiodarone was approved in 1995 for the treatment of malignant and resistant ventricular arrhythmia. Although it is an "old drug," much has been learned recently about this complex drug and its application in a variety of cardiac arrhythmias. The objectives of this review were to summarize what is known about intravenous amiodarone, including its pharmacologic and electrophysiologic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Critical Care Nurse
سال: 2019
ISSN: 0279-5442,1940-8250
DOI: 10.4037/ccn2019381